Pamela Chan
Genentech
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Immune Cell Function and Interaction
Most-Cited Works
- → Novel Foxo1-dependent transcriptional programs control Treg cell function(2012)399 cited
- → Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice(2009)252 cited
- → Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection(2009)248 cited
- → A strategy for risk mitigation of antibodies with fast clearance(2012)246 cited
- → Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model(2020)226 cited
- → Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin(2012)203 cited
- → T Cell-Derived Protein S Engages TAM Receptor Signaling in Dendritic Cells to Control the Magnitude of the Immune Response(2013)181 cited
- → The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated Inflammation(2016)127 cited
- → The Immunoglobulin Superfamily Receptome Defines Cancer-Relevant Networks Associated with Clinical Outcome(2020)108 cited
- → The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity(2016)91 cited